New clot-busting drug developed by researchers can cut the chances of type 2 diabetes patients developing heart disease.
Heart disease is the major cause of reduced life expectancy in patients with diabetes who have about twice the risk of developing a range of cardiovascular diseases.
AdvertisementThe discovery, which is published in the journal Diabetologia, found that a daily treatment of patients with the drug, which is called N-acetylcysteine, reduces clot formation in the blood and is more effective than aspirin, the Daily Express reported.
Researchers at the University of the Highlands and Islands say the clot-busting drug is currently licensed for use in reversing the harmful effects of a paracetamol overdose.
You May Also Like